SUN-LB043 Phase 2 Randomized Study of the Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Hypogonadism

Introduction: Metastatic renal cell carcinoma (mRCC) can cause hypogonadism as an adverse effect in male patients. Hypogonadism can also result from adverse effects of targeted therapy of mRCC, such as fatigue, pain, anorexia, asthenia or hypothyroidism. The objective of this multicenter randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Tishova, Yuliya, Zukov, Ruslan, Borisov, Pavel, Bondarenko, Anastasia, Zakurdaeva, Kristina, Tsimafeyeu, Ilya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552752/
http://dx.doi.org/10.1210/js.2019-SUN-LB043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552752/
http://dx.doi.org/10.1210/js.2019-SUN-LB043

Ejemplares similares